Riskpilot← Back to searchSign inGet full accessPalvamed Oy
OYDissolvedY-tunnus 2780460-7Helenankuja 4-aMedical specialists activities · NACE 8622Est. 20161 employees
Revenue 2025
EUR 328K
+11% vs 2024
EBITDA margin
28.9%
-81% vs 2024
Equity ratio
98.2%
Financial strength
Net profit 2025
EUR 74K
+3% vs 2024
| Revenue | EUR 328K | +11% |
| EBITDA | EUR 95K | -81% |
| Net profit | EUR 74K | +3% |
| Total assets | EUR 371K | +14% |
| Equity | EUR 364K | +15% |
| Employees | 1 | — |
Legal name
Palvamed Oy
Y-tunnus number
2780460-7
Legal form
Osakeyhtiö
NACE code
8622 · Medical specialists activities
Founded
7. syyskuuta 2016
Share capital
EUR 2 500
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-10-31
Financial year
January – December
Company purpose
Yhtiön toimiala on Lääkäripalvelujen ja hammaslääkäripalvelujen tuottaminen potilaille, alan koulutus- ja konsultointipalvelujen tuottaminen, luennointi sekä kustannustoiminta. Yhtiö voi omistaa, hallita ja vuokrata kiinteistöjä, liike- ja asuinhuoneistoja sekä kulkuneuvoja. Yhtiö voi harjoittaa arvopaperikauppaa.
Address
Helenankuja 4-a
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 208 | 237 | 269 | 295 | 328 |
| Staff expenses | −88 | −109 | −102 | 130 | −153 |
| EBITDA | 73 | 75 | 101 | 501 | 95 |
| Depreciation & amort. | −7 | −5 | −4 | 4 | −3 |
| EBIT | 66 | 70 | 97 | 85 | 91 |
| Net financials | −0 | −0 | −2 | 3 | 1 |
| Profit before tax | 66 | 70 | 95 | 89 | 92 |
| Tax | 13 | 14 | 20 | 17 | −18 |
| Net profit | 53 | 56 | 76 | 71 | 74 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 186 | 222 | 275 | 324 | 371 |
| Equity | 164 | 206 | 266 | 316 | 364 |
| Long-term debt | 5 | 0 | 0 | — | — |
| Short-term debt | 17 | 16 | 9 | 8 | 7 |
| Total debt | 22 | 16 | 9 | 8 | 7 |
EBITDA margin
28.9%
This company
15.8%
Market median
+83% vs market
20212025
Equity ratio
98.2%
This company
38.2%
Market median
+157% vs market
20212025
Return on equity
20.2%
This company
18.4%
Market median
+10% vs market
20212025
Net profit margin
22.5%
This company
8.1%
Market median
+178% vs market
20212025
Asset turnover
0.88×
This company
1.12×
Market median
+21% vs market
20212025
Debt / equity
0.02×
This company
0.62×
Market median
+97% vs market
20212025
- Annual report 2025Filed via PRH / YTJ · Period 2024-11-01 – 2025-10-31
- Annual report 2024Filed via PRH / YTJ · Period 2023-11-01 – 2024-10-31
- Annual report 2023Filed via PRH / YTJ · Period 2022-11-01 – 2023-10-31
- Annual report 2022Filed via PRH / YTJ · Period 2021-11-01 – 2022-10-31
- Annual report 2021Filed via PRH / YTJ · Period 2020-11-01 – 2021-10-31
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
KA Chief Executive Officer | Chief Executive Officer | 2016 |
OA Deputy Member | Deputy Member | 2016 |
JA | Audit | 2023 |
PR Deputy auditor | Deputy auditor | 2023 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Palvamed Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kirsi Anneli Palva | Chief Executive Officer | 0 companies |
| Otto Akseli Palva | Deputy Member | 0 companies |
| Jose Adam Juhani Kautonen | Audit | 0 companies |
| Petteri Raine Lagus | Deputy auditor | 0 companies |